-
EP0005610
European procedure
Extract from the Register of European Patents
EP About this file: EP0005610
| EP0005610 - 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.09.2016 Database last updated on 02.11.2024 | Most recent event Tooltip | 14.09.2016 | No opposition filed within time limit | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [1980/11] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutsebaan 30 B-2340 Beerse / BE | ||
| Former [1980/11] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutsebaan 30 Beerse / BE | Inventor(s) | 01 /
Kennis, Ludo Parklaan 5 B-2350 Vosselaar / BE | [N/P] | Representative(s) | Grundy, Derek George Ritchie, et al CARPMAELS & RANSFORD 43, Bloomsbury Square London WC1A 2RA / GB | [1982/50] | Application number, filing date | 79300791.5 | 09.05.1979 | Priority number, date | US19780904845 | 11.05.1978 Original published format: US 904845 | US19780969513 | 14.12.1978 Original published format: US 969513 | Filing language | EN | Procedural language | EN | Publication | Type: | A3 Search report | No.: | EP0005610 | Date: | Status: | (deleted) | [N/P] | Type: | A2 Application without search report | No.: | EP0005610 | Date: | 28.11.1979 | Language: | EN | [N/P] | Type: | B1 Patent specification | No.: | EP0005610 | Date: | 15.12.1982 | Language: | EN | [1982/50] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.10.1979 | Classification | IPC: | C07D403/06, C07D405/12, A61K31/415 | [1982/50] | CPC: |
C07D405/14 (EP,US);
C07D403/06 (EP,US)
| Designated contracting states | AT, BE, CH, DE, FR, GB, IT, LU, NL, SE | Title | German: | 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-one, Verfahren zu deren Herstellung, ihre pharmazeutischen Zusammensetzungen und ihre Verwendung als Beta-Adrenolytika | English: | 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers | French: | 1-(Hétérocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, leur préparation, leurs compositions pharmaceutiques et leur utilisation comme bêta-adrénolytiques | Examination procedure | 12.06.1980 | Examination requested [1980/18] | 13.11.1980 | Despatch of a communication from the examining division (Time limit: M04) | 11.03.1981 | Reply to a communication from the examining division | 01.06.1982 | Despatch of communication of intention to grant (Approval: ) | 14.06.1982 | Communication of intention to grant the patent | 22.06.1982 | Fee for grant paid | 22.06.1982 | Fee for publishing/printing paid | Opposition(s) | 15.09.1983 | No opposition filed within time limit [ N /P ] | Fees paid | Renewal fee | 18.05.1981 | Renewal fee patent year 03 | 14.05.1982 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]FR2218100 (JANSSEN PHARMACEUTICA NV [BE]); | [A]FR2346350 (JANSSEN PHARMACEUTICA NV [BE]); | [A]FR2361889 (JANSSEN PHARMACEUTICA NV [BE]) |